Concepedia
Statistics
Publications
5
Citations
101
H-Index
Active since
2014
Affiliations
Memorial Sloan Kettering Cancer Center(Current)
Novartis (United States)
The Barbara Ann Karmanos Cancer Institute
Novartis (Switzerland)
Tris Pharma (United States)
SG Bhansali is an author at Memorial Sloan Kettering Cancer Center specializing in pharmacology, oncology, and medicine.
Publications per year
2014–2016
Abstract P3-14-01: Phase Ib/II study of ribociclib and alpelisib and letrozole in ER+, HER2– breast cancer: Safety, preliminary efficacy and molecular analysis
Dejan Juric, Roohi Ismail‐Khan, Mario Campone et al. · Cancer Research · 2016 · 37 citations
Medicine, Oncology, Pharmacology +17
Phase Ib/Ii Study of Lee011 (Cdk4/6 Inhibitor) and Lgx818 (Braf Inhibitor) in Braf-Mutant Melanoma
Michael Taylor, Jeff Sosman, R. Gonzalez et al. · Annals of Oncology · 2014 · 21 citations
Medicine, Oncology, Pharmacology +16
Abstract P6-13-01: Triplet therapy with ribociclib, everolimus, and exemestane in women with HR+/HER2– advanced breast cancer
Aditya Bardia, Shanu Modi, Maíra Rodrigues Oliveira et al. · Cancer Research · 2016 · 18 citations
Population Pharmacokinetics of Inhaled Tobramycin Powder in Cystic Fibrosis Patients
Lillian Ting, Sergey Aksenov, SG Bhansali et al. · CPT Pharmacometrics & Systems Pharmacology · 2014 · 14 citations · Full text
Pharmacy, Pharmacokinetics, Pharmacology +17
Phase I Study of Lee011 (Cdk4/6 Inhibitor) in Patients with Malignant Rhabdoid Tumors, Neuroblastoma, and Cyclin D–Cdk4/6 Pathway-Activated Tumors
Birgit Geoerger, Franck Bourdeaut, Steven G. DuBois et al. · Annals of Oncology · 2014 · 11 citations
Medicine, Oncology, Pharmacology +14
1–5 of 5